This was also observed among patients with T2D [ n = 304] (− 31.9 mg/dL at 1 year, P < 0.0001); there was a numerical trend towards reduced FPG in patients with T1D [ n = 14], but this was not significant (− 36.7 mg/dL at 1 year, P > 0.05 [Supplementary Material Fig.
← all excerpts
Long-Term Safety and Clinical Outcomes with Insulin Degludec/Insulin Aspart Treatment in Japanese Patients with Diabetes: A Real-World, Prospective, Observational Study.
1
—
—